Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Following publication of the original article [1], the author reported that an author name, Roberta Zappasodi, was missed in the authorship list.

Bibliographic Details
Main Authors:	Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Chowell, Lisa M. Coussens, Daniel D. De Carvalho, David G. DeNardo, Jérôme Galon, Howard L. Kaufman, Tomas Kirchhoff, Michael T. Lotze, Jason J. Luke, Andy J. Minn, Katerina Politi, Leonard D. Shultz, Richard Simon, Vésteinn Thórsson, Joanne B. Weidhaas, Maria Libera Ascierto, Paolo Antonio Ascierto, James M. Barnes, Valentin Barsan, Praveen K. Bommareddy, Adrian Bot, Sarah E. Church, Gennaro Ciliberto, Andrea De Maria, Dobrin Draganov, Winson S. Ho, Heather M. McGee, Anne Monette, Joseph F. Murphy, Paola Nisticò, Wungki Park, Maulik Patel, Michael Quigley, Laszlo Radvanyi, Harry Raftopoulos, Nils-Petter Rudqvist, Alexandra Snyder, Randy F. Sweis, Sara Valpione, Roberta Zappasodi, Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, Alessandra Cesano, Francesco M. Marincola, Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2019-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	http://link.springer.com/article/10.1186/s40425-019-0640-y

Similar Items

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
by: Davide Bedognetti, et al.
Published: (2019-05-01)

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
by: Bedognetti, Davide, et al.
Published: (2020)

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
by: Lisa H. Butterfield, et al.
Published: (2018-12-01)

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
by: Balwit James M, et al.
Published: (2010-12-01)

Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
by: Maria L. Ascierto, et al.
Published: (2020-06-01)

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
by: Disis Mary L, et al.
Published: (2011-09-01)

Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
by: James L. Gulley, et al.
Published: (2017-07-01)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
by: I. Puzanov, et al.
Published: (2017-11-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
by: Rajeev Sharma, et al.
Published: (2021-06-01)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)

SITC 26<sup>th</sup> annual meeting – summary
by: Romano Emanuela, et al.
Published: (2012-05-01)

The Relationship of SITC’s Assets Under Management And Its Brand Image
by: Kuo, Wen-Chin, et al.
Published: (2014)

The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
by: Michael M Boyiadzis, et al.
Published: (2020-07-01)

Wasilah mesej melayu melalui penyair zaman SITC (1922-1957)
by: Naffi Mat, et al.
Published: (2014)

The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program
by: Urba Walter J, et al.
Published: (2011-01-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
by: Gary D Steinberg, et al.
Published: (2021-07-01)

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
by: Kavita Dhodapkar, et al.
Published: (2020-07-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
by: Ronald Levy, et al.
Published: (2020-07-01)

External Trade of Taiwan under Japan's Colony (1896-1948) by SITC Analysis
by: Ya-hsiang Wei, et al.
Published: (2005)

Correction: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
by: Gavin Thurston, et al.
Published: (2021-01-01)

33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Published: (2018-11-01)

33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Published: (2018-11-01)

Long-term Development of Time Series in Foreign Trade of the Czech Republic According to SITC Categories
by: Jana Stávková, et al.
Published: (2004-01-01)

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
by: Sneha Berry, et al.
Published: (2019-02-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
by: Frederick L Locke, et al.
Published: (2020-07-01)

34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 2
Published: (2019-11-01)

34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 1
Published: (2019-11-01)

Melanoma: from incurable beast to a curable bet. The success of immunotherapy
by: Maria Libera Ascierto, et al.
Published: (2015-07-01)

33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018): Late-Breaking Abstracts
Published: (2018-12-01)

The research of Taiwan mutual fund online-trading model uses Polaris SITC's P-saving as one of the examples
by: HAN -CHANG LIAO, et al.
Published: (2013)

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond
by: Paolo A. Ascierto, et al.
Published: (2015-02-01)

Adjuvant therapy of melanoma with interferon: lessons of the past decade
by: Kirkwood John M, et al.
Published: (2008-10-01)

Combination therapy: the next opportunity and challenge of medicine
by: Marincola Francesco M, et al.
Published: (2011-07-01)

Correction: Defining current gaps in quality measures for cancer immunotherapy: consensus report from the society for immunotherapy of cancer (SITC) 2019 Quality Summit
by: Christopher R Heery, et al.
Published: (2020-06-01)

Editorial: Combination strategies in the treatment of Melanoma
by: Paolo Antonio eAscierto
Published: (2016-03-01)

[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]
by: Lorenzo Pradelli, et al.
Published: (2017-09-01)

[Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]
by: Lorenzo Pradelli, et al.
Published: (2016-12-01)

Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit
by: Howard L Kaufman, et al.
Published: (2020-06-01)

Current opportunities to catalyze research in nutrition and cancer prevention – an interdisciplinary perspective
by: The Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group
Published: (2019-07-01)

Considering Interactions among Multiple Criteria for the Server Selection
by: Vesna Čančer
Published: (2010-06-01)

Cannot write session to /tmp/vufind_sessions/sess_k1720q5an2iu09rbo0agnauhfi